🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

9550+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 9550 recruiting trials

Phase 4RecruitingNCT05936580

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

👨‍⚕️ Johannes Oldenburg, Experimental Haematology and Transfusion Medicine, University Clinic Bonn📍 15 sites📅 Started Apr 2026View details ↗
NARecruitingNCT06714097

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

🏥 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta📍 1 site📅 Started Apr 2026View details ↗
Phase 2RecruitingNCT07175441

Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma

🏥 Riboscience, LLC.📍 3 sites📅 Started Apr 2026View details ↗
RecruitingNCT07501858

Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome

🏥 Center of New Medical Technologies📍 1 site📅 Started Apr 2026View details ↗
Phase 3RecruitingNCT07422480

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

👨‍⚕️ Study Director, Takeda📍 146 sites📅 Started Apr 2026View details ↗
Phase 2RecruitingNCT07326566

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

🏥 Black Diamond Therapeutics, Inc.📍 2 sites📅 Started Apr 2026View details ↗
Phase 4RecruitingNCT06979492

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

👨‍⚕️ Ross Fasano, MD, Emory University📍 1 site📅 Started Apr 2026View details ↗
Phase 1, PHASE2RecruitingNCT07501559

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

🏥 Jecho Biopharmaceuticals Co., Ltd.📍 1 site📅 Started Apr 2026View details ↗
Phase 1RecruitingNCT07469891

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

🏥 Prelude Therapeutics📍 1 site📅 Started Apr 2026View details ↗
Phase 3RecruitingNCT06752356

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

👨‍⚕️ Miranda Norton, PhD, Kedrion S.p.A.📍 1 site📅 Started Apr 2026View details ↗
RecruitingNCT07464470

Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers

👨‍⚕️ Alexey Tryakin, MD, PhD, professor, Blokhin's Russian Cancer Research Center📍 1 site📅 Started Apr 2026View details ↗
Phase 3RecruitingNCT05199688

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 12 sites📅 Started Mar 2026View details ↗
Phase 3RecruitingNCT07154745

A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 5 sites📅 Started Mar 2026View details ↗
Phase 2RecruitingNCT07124078

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

👨‍⚕️ Incyte Medical Monitor, Incyte Corporation📍 38 sites📅 Started Mar 2026View details ↗
Phase 1, PHASE2RecruitingNCT07302347

A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 1 site📅 Started Mar 2026View details ↗
Phase 1RecruitingNCT07441694

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

👨‍⚕️ Incyte Medical Monitor, Incyte Corporation📍 45 sites📅 Started Mar 2026View details ↗
Phase 1, PHASE2RecruitingNCT06465199

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

👨‍⚕️ Giselle Saulnier Sholler, MD, Penn State Health Children's Hospital📍 6 sites📅 Started Mar 2026View details ↗
Phase 4RecruitingNCT07502378

Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency

👨‍⚕️ Pedram Hamrah, MD, University of South Florida📍 1 site📅 Started Mar 2026View details ↗
Phase 3RecruitingNCT07300514

Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma

👨‍⚕️ Rong Tao, MD &PhD, Fudan University📍 1 site📅 Started Mar 2026View details ↗
Phase 1RecruitingNCT07388563

Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

👨‍⚕️ Max J Gordon, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Mar 2026View details ↗
← PreviousPage 3 of 478Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →